Samarium-153 ethylenediamine tetramethylene phosphonate therapy for bone pain palliation in skeletal metastases

Indian Journal of Cancer

Volumn 43, Issue 2, 2006, Pages 86-92

  Tripathi, Madhavi ^a   Singhal, T ^a   Chandrasekhar, N ^a   Kumar, P ^a   Bal, C ^a   Jhulka, P K ^a   Bandopadhyaya, G ^a   Malhotra, A ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Bone neoplasms; Bone pain; Humans; Myelotoxicity; Palliation; Palliative care; Secondary; Sm 153 EDTMP; Strontium radioisotopes; Therapeutic use

Indexed keywords

EID: 33745626738     PISSN: 0019509X     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-509X.25890     Document Type: Article

References (21)

1. Hoskin PJ. Radiotherapy for bone pain. Pain 1995;63:137-9.
2. Dearnaley DP, Bayly RJ, A'Hern RP, Gadd J, Zivanovic MM, Lewington VJ. Palliation of bone metastases in prostate cancer. Hemibody irradiation or strontium-89? Clin Oncol 1992;4:101-7.
3. Serafini AN. Current status of systemic intravenous radiopharmaceuticals for the treatment of painful metatstatic bone disease. Int J Radiat Oncol Biol Phys 1994;30: 1187-94.
4. McEwan AJ. Unsealed source therapy of painful bone metastases:an update. Semin Nucl Med 1997;27: 165-82.
5. Serafini AN. Therapy of metastatic bone pain. J Nucl Med 2001;42:895-906.
6. Turner JH, Claringbold PG, Hetherington EL, Sorby P, Martindale AA. A phase I study of samarium-153 ehylenediaminetetramethylene phosphonate therapy for disseminated skeletal metastases. J Clin Oncol 1989;7:1926-31.
7. Podoloff DA, Kasi LP, Kim EE, Fossella FV, Bhadkamar VA. Evaluation of Sm-153 EDTMP as a bone imaging agent during a therapeutic trial. J Nucl Med 1991;32:A918.
8. Eary JF, Collins C, Stabin M, Vernon C, Petersdorf S, Baker M, et al. Sm-153-EDTMP biodistribution and dosimetry estimation. J Nucl Med 1993;34:1031-6.
9. Turner JH, Claringbold PG. A phase II study of treatment of painful multifocal skeletal metastases with single and repeated dose of samarium-153 ethylenediaminetetramethylene phosphonate. Eur J Cancer 1991;27:1084-6.
10. Soloway MS, Hardeman SW, Hickey D, Raymond J, Todd B, Soloway S, et al. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer 1988;61:195-202.
11. Collins C, Eary JF, Donaldson G, Vernon C, Bush NE, Petersdorf S, et al. Samarium-153 EDTMP in bone metastases of hormone refractory prostate carcinoma. A phase I/II trial. J Nucl Med 1993;34:1839-44.
12. Reschel, Chatal JF, Pecking A, EII P, Duchesne G, Rubens R, et al. A dose-controlled study of Sm-153 EDTMP in the treatment of patients with painful bone metastases. Eur J Cancer 1997;33: 1583-91.
13. Serafini AN, Houston SJ, Resch I, Quick DP, Grund FM, EII PJ, et al. Palliation of pain associated with metastatic bone cancer using samarium-153 Lexidronam: A double-blind:a double blind placebo controlled clinicak trial. J Clin Oncol 1998; 16: 1574-81.
14. Tian JH, Zhang JM, Hou QT, Oyang QH, Wang JM, Luan ZS, et al. Multicentre trial on the efficacy and toxicity of single-dose samarium-153-ethylene diamine tetramethylene phosphonate as a palliative treatment for painful skeletal metastases in China. Eur J Nucl Med 1999;26:2-7.
15. Li L, Liang Z, Deng H, Kuang A, Tan T, Luo S. Samarium-153-EDTMP bone uptake rate and its relation to therapeutic effect. Chin Med J 2002;115: 1096-8.
16. Dolezal J, Vizd'a J, Cermakova E. Myelotoxicity after systemic radionuclide therapy of painful bone metastases with 153Samarium-EDTMP. Vnitr Lek 2003;49:189-93.
17. Wu H, Tan T, Fang L, Zhang X. Evaluation of efficacy of Sm-153-EDTMP in patients with painful bone metastases of breast cancer. Sichun Da Xue Bao Yi Xue Ban 2003;34:716-8.
18. Turner JH, Martindale AA, Sorby P, Hetherington EL, Fleay RF, Hoffman RF, et al. Samarium-153 EDTMP therapy of disseminated skeletal metastases. Eur J Nucl Med 1989; 15:784-95.
19. Jacobs SC. Spread of prostatic cancer to bone. Urology 1983; 1:337-40.
20. Mc Neil BJ. Value of bone scanning in neoplastic diseases. Semin Nucl Med 1984; 14:277-86.
21. Friedland J. Local and systemic radiation for palliation of metastatic disease. Urol Clin N Am 1999;26:391-402.